Barings’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-49,892
Closed -$4.95M 705
2019
Q3
$4.95M Buy
49,892
+12
+0% +$1.14K 0.11% 165
2019
Q2
$4.61M Sell
49,880
-18,087
-27% -$1.72M 0.1% 173
2019
Q1
$6.41M Buy
67,967
+32,100
+89% +$2.81M 0.15% 117
2018
Q4
$2.3M Sell
35,867
-32,064
-47% -$2.37M 0.04% 239
2018
Q3
$6.08M Buy
67,931
+20,264
+43% +$1.79M 0.09% 156
2018
Q2
$3.79M Sell
47,667
-247
-0.5% -$20.5K 0.05% 223
2018
Q1
$4.27M Hold
47,914
0.06% 215
2017
Q4
$5M Sell
47,914
-19,410
-29% -$2.19M 0.07% 206
2017
Q3
$9.82M Buy
67,324
+31,350
+87% +$4.27M 0.18% 87
2017
Q2
$4.67M Sell
35,974
-27,774
-44% -$3.4M 0.14% 135
2017
Q1
$7.93M Buy
63,748
+31,874
+100% +$3.81M 0.09% 218
2016
Q4
$3.69M Buy
31,874
+7,620
+31% +$849K 0.09% 137
2016
Q3
$2.54M Buy
+24,254
New +$2.62M 0.07% 222
2016
Q1
Sell
-40,794
Closed -$4.88M 1020
2015
Q4
$4.88M Sell
40,794
-16,750
-29% -$1.94M 0.12% 101
2015
Q3
$6.22M Buy
57,544
+30,470
+113% +$3.78M 0.15% 79
2015
Q2
$3.13M Sell
27,074
-13,920
-34% -$1.59M 0.09% 217
2015
Q1
$4.73M Buy
40,994
+11,890
+41% +$1.42M 0.11% 134
2014
Q4
$3.26M Buy
29,104
+11,770
+68% +$1.24M 0.07% 209
2014
Q3
$1.64M Buy
17,334
+2,300
+15% +$208K 0.04% 354
2014
Q2
$1.29M Sell
15,034
-30,900
-67% -$2.35M 0.04% 435
2014
Q1
$3.21M Sell
45,934
-32,860
-42% -$2.6M 0.1% 198
2013
Q4
$6.66M Sell
78,794
-5,080
-6% -$402K 0.28% 78
2013
Q3
$6.46M Buy
83,874
+13,680
+19% +$959K 0.28% 76
2013
Q2
$4.1M Buy
+70,194
New +$4.22M 0.18% 111

Other funds holding CELG

Barings's CELG Position: Q4 2019 in Review

Barings sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 49,892 shares — an estimated $4.95M sold.

Barings first reported a position in CELG in Q2 2013 and held it in 24 quarters. The position peaked at $9.82M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Barings reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Barings sold 49,892 Celgene Corp shares in Q4 2019, an estimated $4.95M.
  • Barings first reported a position in Celgene Corp in Q2 2013 and held it in 24 quarters.
  • Barings's Celgene Corp position peaked at $9.82M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Barings's 13F filing for Q4 2019, filed 14 Feb 2020.